Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0820
+0.0020 (2.50%)
At close: Sep 8, 2026
RMTG Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -8.82 | -7.81 | -5.56 | -9.81 | -5.51 | -12.88 |
Depreciation & Amortization | 0.36 | 0.28 | 0.22 | 0.31 | 0.15 | 0.04 |
Other Amortization | 2.38 | 1.37 | 2.13 | 3.06 | 1.76 | 0.89 |
Asset Writedown & Restructuring Costs | - | - | - | 4.13 | - | - |
Stock-Based Compensation | - | - | - | 0 | 0.01 | 0.28 |
Other Operating Activities | -0.75 | -0.48 | 0 | -1.52 | -0.08 | 0.26 |
Change in Accounts Receivable | -0.07 | -0.02 | 0 | 0.03 | -0.03 | -0 |
Change in Inventory | -0.38 | -0.15 | -0.01 | - | - | - |
Change in Accounts Payable | 7.79 | 6.15 | 4.1 | 3.41 | 2.52 | 1.31 |
Change in Other Net Operating Assets | -0.25 | -0.04 | -0.03 | -0.02 | - | 0.24 |
Operating Cash Flow | 0.27 | -0.71 | 0.85 | -0.42 | -1.11 | -9.88 |
Operating Cash Flow Growth | 141.19% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.85 | -0.6 | -0.22 | -0.39 | -0.2 | - |
Cash Acquisitions | - | - | - | - | - | 0.67 |
Investing Cash Flow | -0.85 | -0.6 | -0.22 | -0.39 | -0.2 | 0.67 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 1.1 | - | - | - | 12.4 |
Total Debt Issued | 0.29 | 1.1 | - | - | - | 12.4 |
Long-Term Debt Repaid | - | - | - | -0.01 | -0.02 | -0.25 |
Total Debt Repaid | - | - | - | -0.01 | -0.02 | -0.25 |
Net Debt Issued (Repaid) | 0.29 | 1.1 | - | -0.01 | -0.02 | 12.15 |
Other Financing Activities | - | - | - | -0.3 | - | - |
Financing Cash Flow | 0.29 | 1.1 | - | -0.31 | -0.02 | 12.15 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -0.29 | -0.21 | 0.64 | -1.11 | -1.33 | 2.94 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.58 | -1.31 | 0.64 | -0.8 | -1.31 | -9.88 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6.19% | -25.67% | 15.47% | -33.40% | -85.78% | -2255.99% |
Free Cash Flow Per Share | -0.04 | -0.10 | 0.05 | -0.07 | -0.11 | -0.86 |
Levered Free Cash Flow | 5.95 | 4.25 | 2.76 | 0.59 | 0.57 | -4.74 |
Unlevered Free Cash Flow | 9.59 | 7.54 | 4.16 | 1.59 | 1.56 | -3.93 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | 0 | 0 | 0 |
Change in Working Capital | 7.09 | 5.94 | 4.06 | 3.42 | 2.49 | 1.55 |